)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Gentian Diagnostics
Gentian Diagnostics (GENT) investor relations material
Gentian Diagnostics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary11 Feb, 2026
Executive summary
Achieved record quarterly sales of NOK 46.6 million in Q4 2025, up 9% year-over-year, and full-year sales of NOK 176.5 million, a 16% increase over 2024, with 17% organic growth and strong profitability improvements.
EBITDA reached NOK 10.5 million in Q4 2025 and NOK 34.6 million for the year, up 40% year-over-year.
Cystatin C sales grew 32% for the year, with strong momentum in the US (146% growth) and China, and better-than-expected performance despite local cost containment.
Announced an exclusive partnership with a leading global diagnostics company for a new assay, targeting commercial launch in H2 2027.
Board proposes a dividend of NOK 0.60 per share, up 50% from the previous year, reflecting strong cash position and earnings.
Financial highlights
Gross margin improved to 58% in Q4 2025 and 56% for the year, approaching the long-term target of 60%.
Net profit for FY25 was NOK 13.3 million, lower than 2024 due to a one-time tax effect in 2024.
Cash position at year-end was NOK 105.9 million, up from NOK 84.7 million, with no interest-bearing debt and an equity ratio near 80%.
Free cash flow in Q4 2025 was NOK 20.1 million, up from NOK -8.5 million in Q4 2024.
81% of Q4 2025 sales came from long-term contracts.
Outlook and guidance
Positive outlook for 2026, especially for Cystatin C and fCAL turbo, with continued investments in US expansion and R&D.
Sustained growth expected for Cystatin C in the US and China, with cautious outlook for China due to market reforms.
Expectation of continued profitable growth and new product launches, including a new partner-developed assay.
Revised NT-proBNP assay development timeline to be presented in Q2 2026 after assay redesign.
Ambition to maintain gross margin in the 55%-60% range at current revenue levels.
NT-proBNP assay redesign timeline update?
U.S. Cystatin C growth drivers beyond KDIGO?
High-sensitivity tech: partner engagement status?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Gentian Diagnostics earnings date
Status update25 Feb, 2026
Gentian Diagnostics
Next Gentian Diagnostics earnings date
Status update25 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Gentian Diagnostics ASA is a Norwegian company that specializes in the development and production of in-vitro diagnostic (IVD) reagents. The company’s focus is on creating biochemical reagents for use in clinical chemistry analyzers, particularly utilizing Particle-Enhanced Turbidimetric Immunoassays (PETIA). These assays enable faster, automated testing for various medical conditions, improving operational efficiency for clinical labs. Gentian’s products target key areas such as infections, inflammation, kidney disease, cardiac conditions, and veterinary medicine. Gentian Diagnostics is headquartered in Moss, Norway, and its shares are listed on the Oslo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage